A Phase 1 Study of WVE-007 in Adults Living with Overweight or Obesity

2024-520203-41-00 Protocol WVE-007-001 Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 25 Jul 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 2 sites · Protocol WVE-007-001

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 136
Countries 1
Sites 2

Adults Living with Overweight and Obesity

Key facts

Sponsor
Wave Life Sciences Ireland Limited
Participant type
Patients
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Nutritional and Metabolic Diseases [C18]
Trial duration
25 Jul 2025 → ongoing
Decision date (initial)
2025-06-23
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-520203-41-00
ClinicalTrials.gov
NCT06842186

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Adults Living with Overweight and Obesity

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Wave Life Sciences Ireland Limited

Sponsor organisation
Wave Life Sciences Ireland Limited
Address
One Spencer Dock, Spencer Dock Spencer Dock
City
Dublin 1
Postcode
D01 X9R7
Country
Ireland

Scientific contact point

Organisation
Wave Life Sciences Ireland Limited
Contact name
Clinical Operations

Public contact point

Organisation
Wave Life Sciences Ireland Limited
Contact name
Clinical Operations

Locations

1 EU/EEA country · 2 investigational sites

By country

CountryMS statusPlanned subjectsSites
Romania Ongoing, recruiting 34 2
Rest of world
Moldova, Republic of, United Kingdom
102

Investigational sites

Romania

2 sites · Ongoing, recruiting
Arensia Clinics S.R.L.
Ph. I Unit-ArensiaEM in collab. with Arensia Clinics, 3rd Floor, Wards 1,2,3,4,5,6 and 7, Intrarea Tudor Stefan 38-40, 011658, Bucharest
Spitalul Clinic Judetean De Urgenta Cluj
Ph.I Unit-AEM in collab. with County Emg. Hospital Cluj Ophthalm. build., 1st fl, wrds 33,34,35, Strada Clinicilor 3-5, 400006, Cluj-Napoca

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Romania 2025-07-25 2025-07-25

Application history

5 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-03-03 Romania No conclusion
2025-06-17
2025-06-23
2 NON SUBSTANTIAL MODIFICATION NSM-1 2025-06-25 Romania No conclusion
2025-06-17
2025-06-25
3 NON SUBSTANTIAL MODIFICATION NSM-2 2025-07-04 Romania No conclusion
2025-06-17
2025-07-04
4 NON SUBSTANTIAL MODIFICATION NSM-3 2025-07-24 Romania No conclusion
2025-06-17
2025-07-24
5 NON SUBSTANTIAL MODIFICATION NSM-4 2025-08-29 Romania No conclusion
2025-06-17
2025-08-29